Marcelyne Joseney-Antoine

Marcelyne Joseney-Antoine currently serves as Clinical Operations Asset Lead for Hematology at Spark Therapeutics, Inc., since September 2017, after holding the position of Sr. Clinical Project Manager. Prior experience includes roles at bluebird bio as Clinical Trial Manager, leading the sickle cell program and managing cross-functional teams and vendors, as well as serving as Global Clinical Trial Lead at Verastem for a Phase II registration trial. Additional positions include Clinical Research Manager I at Millennium Pharmaceuticals, Clinical Research Scientist at Seaside Therapeutics, Sr. Clinical Trial Coordinator at Biogen Idec, and Clinical Trial Associate at Pfizer and PAREXEL. Marcelyne Joseney-Antoine holds a B.S. in Biological Sciences from the University of Massachusetts Lowell, obtained in 2005.